Corcept Therapeutics · 1 day ago
Emerging Markets Intern
Corcept Therapeutics is a leading company in the research and development of cortisol modulators. They are seeking an intern to support the Emerging Markets Marketing team in building plans for patient advocacy events and creating marketing collateral.
BiotechnologyMedicalPharmaceutical
Responsibilities
Contribute to the marketing and engagement plan for several local advocacy events in ALS
Collaborate with marketing team to create a “launch-in-a-box” with marketing plan and collateral & assets for any future advocacy events in ALS
Partner with corporate communications to not only drive interest and publicity externally, but also support internal communications and engagement
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Qualification
Required
Excellent creative, problem solving, organizational and communication skills
Ability to balance creativity and execution in a timely manner
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week); flexibility to extend internship to the end of October preferred
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Excellent communication and collaboration skills, with the ability to work effectively across cross-functional teams
Ability to flex and thrive in an ambiguous environment undergoing transformational change
Experience working in marketing, marketing production, marketing technology or marketing operations
Proficiency in Microsoft Excel and PowerPoint
Bachelor's degree with a marketing focus preferred
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Recent News
2026-01-07
Company data provided by crunchbase